At a glance
- Originator Kyowa Hakko
- Class Antidepressants; Antiepileptic drugs; Antiparkinsonians; Neuroprotectants; Small molecules; Xanthines
- Mechanism of Action Adenosine A2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Parkinson's disease